Company plans to pursue UK authorization in parallel to approval in the U.S. Qnovia, Inc. ("Qnovia"), a pharma company developing inhaled therapeutics with an initial focus on nicotine replacement
LOS ANGELES (BUSINESS WIRE) Respira Technologies, Inc. a clinical-stage company developing inhaled therapeutics for smoking cessation and drug delivery technologies to treat cardiopulmonary diseases has rebranded as “QNOVIA” and adopted Qnovia, Inc. as its corporate name. As part of the rebranding, the company has.